» Articles » PMID: 38024319

The Gut Microbiome Meets Nanomaterials: Exposure and Interplay with Graphene Nanoparticles

Overview
Journal Nanoscale Adv
Specialty Biotechnology
Date 2023 Nov 29
PMID 38024319
Authors
Affiliations
Soon will be listed here.
Abstract

Graphene-based nanoparticles are widely applied in many technology and science sectors, raising concerns about potential health risks. Emerging evidence suggests that graphene-based nanomaterials may interact with microorganisms, both pathogens and commensal bacteria, that dwell in the gut. This review aims to demonstrate the current state of knowledge on the interplay between graphene nanomaterials and the gut microbiome. In this study, we briefly overview nanomaterials, their usage and the characteristics of graphene-based nanoparticles. We present and discuss experimental data from studies, screening tests on small animals and rodent experiments related to exposure and the effects of graphene nanoparticles on gut microbiota. With this in mind, we highlight the reported crosstalk between graphene nanostructures, the gut microbial community and the host immune system in order to shed light on the perspective to bear on the biological interactions. The studies show that graphene-based material exposure is dosage and time-dependent, and different derivatives present various effects on host bacteria cells. Moreover, the route of graphene exposure might influence a shift in the gut microbiota composition, including the alteration of functions and diversity and abundance of specific phyla or genera. However, the mechanism of graphene-based nanomaterials' influence on gut microbiota is poorly understood. Accordingly, this review emphasises the importance of studies needed to establish the most desirable synthesis methods, types of derivatives, properties, and safety aspects mainly related to the routes of exposure and dosages of graphene-based nanomaterials.

Citing Articles

Using In Vitro Models to Study the Interactions Between Environmental Exposures and Human Microbiota.

Cheng Q, Chen S Microorganisms. 2025; 13(2).

PMID: 40005610 PMC: 11857843. DOI: 10.3390/microorganisms13020247.


Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives.

Liu J, Yang F, Hu J, Zhang X CNS Neurosci Ther. 2024; 30(5):e14715.

PMID: 38708806 PMC: 11071172. DOI: 10.1111/cns.14715.


Enhancing the bioavailability and activity of natural antioxidants with nanobubbles and nanoparticles.

colic M, Kraljevic Pavelic S, Persuric Z, Agaj A, Bulog A, Pavelic K Redox Rep. 2024; 29(1):2333619.

PMID: 38577911 PMC: 11000614. DOI: 10.1080/13510002.2024.2333619.

References
1.
Singh Y, Meher J, Raval K, Khan F, Chaurasia M, Jain N . Nanoemulsion: Concepts, development and applications in drug delivery. J Control Release. 2017; 252:28-49. DOI: 10.1016/j.jconrel.2017.03.008. View

2.
Yang Z, Hao X, Chen S, Ma Z, Wang W, Wang C . Long-term antibacterial stable reduced graphene oxide nanocomposites loaded with cuprous oxide nanoparticles. J Colloid Interface Sci. 2018; 533:13-23. DOI: 10.1016/j.jcis.2018.08.053. View

3.
Fadeel B, Bussy C, Merino S, Vazquez E, Flahaut E, Mouchet F . Safety Assessment of Graphene-Based Materials: Focus on Human Health and the Environment. ACS Nano. 2018; 12(11):10582-10620. DOI: 10.1021/acsnano.8b04758. View

4.
Chen M, Yin J, Liang Y, Yuan S, Wang F, Song M . Oxidative stress and immunotoxicity induced by graphene oxide in zebrafish. Aquat Toxicol. 2016; 174:54-60. DOI: 10.1016/j.aquatox.2016.02.015. View

5.
Wu K, Zhou Q, Ouyang S . Direct and Indirect Genotoxicity of Graphene Family Nanomaterials on DNA-A Review. Nanomaterials (Basel). 2021; 11(11). PMC: 8625643. DOI: 10.3390/nano11112889. View